Needham Maintains Buy on Medtronic, Lowers Price Target to $131
Needham analyst Mike Matson maintains Medtronic (NYSE:MDT) with a Buy and lowers the price target from $145 to $131.
Medtronic, Virtua Health Report 5-Year Partnership ‘focused on improving delivery of quality care for residents of South Jersey,’ No Terms Disclosed
Additional, first-in-nation Virtua/Medtronic LABS collaboration to improve health outcomes by removing barriers to access and care
MARLTON, N.J., Dec. 15, 2021 /PRNewswire/ -- Virtua Health and Medtronic plc (NYSE:MDT)
Medtronic Shares Fall After FDA Warning Letter To Its Diabetes Business
Medtronic Plc (NYSE: MDT)
RBC Capital Initiates Coverage On Medtronic with Outperform Rating, Announces Price Target of $140
RBC Capital analyst Shagun Singh initiates coverage on Medtronic (NYSE:MDT) with a Outperform rating and announces Price Target of $140.
Needham Maintains Buy on Medtronic, Lowers Price Target to $145
Needham analyst Mike Matson maintains Medtronic (NYSE:MDT) with a Buy and lowers the price target from $152 to $145.
Medtronic Q2 Sales Hit By By Labor Shortage, COVID-19; Expects Lower Sales Growth Rate For FY22
Medtronic Plc's (NYSE: MDT)
The Week Ahead In Biotech (Nov. 21-Nov. 27): Takeda, Aadi, Fennec FDA Decisions, Earnings In The Spotlight In Holiday-Shortened Week
Biotech stocks showed a lack of direction in the week ending Nov. 19 before finishing modestly higher. Stocks did not have much meaningful catalysts to react to amid the winding down of the reporting season and ahead of the holiday week.
Medtronic’s Intrepid Valve Eliminates Mitral Regurgitation At 30 Days, Study Shows
Medtronic plc (NYSE:MDT) announced early data for its self-expanding Intrepid transcatheter mitral valve replacement (TMVR) system for mitral valve regurgitation (MR)…
Medtronic Touts 5-Year Data Of Self-Expanding TAVR Platform
Medtronic plc (NYSE:MDT) presented five-year clinical data for CoreValve and Evolut transcatheter aortic valve implantation (TAVI) platforms at the 33rd Transcatheter…